bivalent mRNA vaccine (ClearB Therapeutics/WuXi AppTec)

N/A

Report date: 2026/01/26 17:59:10

Base Information

Drug Namebivalent mRNA vaccine (ClearB Therapeutics/WuXi AppTec)
Drug Alias NamemRNA vaccine therapy (ClearB Therapeutics/WuXi AppTec)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionHBsAg modulators
TargetsHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesClearB Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesClearB Therapeutics IncWuxi Apptec(Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A